PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 13, 2026Journal of the Pediatric Infectious Diseases Society0 citations

Cerebrospinal pharmacokinetic and pharmacodynamic evaluation of sulbactam: dosing considerations for Acinetobacter baumannii meningitis in pediatric patients

View Full Paper
TOTetsushu OnitaShimane University HospitalKIKazuro IkawaHiroshima University

Key Points

  • The study aims to determine effective sulbactam dosing regimens for treating A. baumannii meningitis in children, factoring in CSF inflammation.
  • Identified dosing regimens for sulbactam
  • Evaluated pharmacokinetics in cerebrospinal fluid (CSF)
  • Considered the degree of inflammation when determining dosing
  • High-dose sulbactam regimens were found beneficial for target attainment in CSF
  • Optimized dosing can enhance treatment effectiveness for A. baumannii meningitis in pediatric cases

Abstract

This study identified effective dosing regimens for A. baumannii meningitis in pediatric patients in consideration of the degree of inflammation in CSF. High-dose sulbactam regimens can be considered to optimize CSF target attainment for A. baumannii meningitis in pediatric patients.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Onita et al. (2026) studied this question.

synapsesocial.com/papers/69b3ace502a1e69014ccef8fhttps://doi.org/10.1093/jpids/piag017
Ask AI
Helpful
Bookmark
Share
View Full Paper